ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026
Bullous pemphigoid following adjuvant radiotherapy for breast cancer: a case report.
Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBullous pemphigoid (BP) is an autoimmune cutaneous blistering disease that predominantly affects elderly patients. Radiotherapy represents a rare triggering factor and may clinically mimic radiation-induced dermatitis, potentially leading to delayed diagnosis. CASE REPORT: An 85-year-old woman underwent breast-conserving surgery and adjuvant radiotherapy for multifocal invasive lobular carcinoma of the right breast. The immediate post-radiotherapy course was unremarkable. Approximately 7 weeks after completion of radiotherapy, the patient developed acute-onset pruritic blistering lesions confined to the irradiated breast, later spreading to the upper arm and back. Initial clinical assessment suggested late-onset radiation dermatitis. Due to the delayed and progressive presentation, further diagnostic evaluation was performed. Histopathology revealed subepidermal blister formation with inflammatory infiltrates. Direct immunofluorescence demonstrated linear IgG and C3 deposition along the basement membrane zone, while serology showed elevated BP230 antibodies, confirming the diagnosis of BP. Treatment with high-potency topical corticosteroids and systemic doxycycline resulted in marked clinical improvement.
conclusionThis case highlights BP as a rare delayed complication of breast radiotherapy. Acute-onset blistering lesions outside the typical timeframe of radiodermatitis should prompt consideration of autoimmune cutaneous disease. Establishing a strong physician-patient relationship combined with an interdisciplinary approach is essential to ensure early diagnosis and favorable clinical outcomes.
Indexed as
Identifiers
42014465What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.